People with existing fatigue conditions Thyroid disorders, chronic fatigue syndrome, fibromyalgia, and depression all cause fatigue that can compound with tirzepatide effects
Keywords: Heart failure with reduced ejection fraction (HFrEF), GLP-1 receptor agonists (GLP-1 RAs), Type 2 diabetes mellitus (T2DM), Cardiovascular outcomes, Dipeptidyl peptidase-4 inhibitors (DPP4i) 1
These adverse effects can persist for several days, and may result in dehydration, which if severe may lead to other serious health complications.3 Nausea is the most common adverse effect reported with GLP-1 agonists with up to 50 percent of patients affected
AbbVie and Genmab made their case for Epkinlys approval with data from the Phase I/II EPCORE NHL-1 trial, where the drug elicited an objective response rate of 82%, including a 60% complete response rate and a 22% partial response rate